Multi-state cannabis operatorMariMed(CSE:MRMD) (OTCQX:MRMD) disclosed its financial results for thesecond quarterended June 30, 2024, revealingrevenue of $40.4 million, compared to $36.5 million in the same period last year.

"With the first half of the year in the books, I'm pleased to say we remain on track to deliver our 2024 financial targets," stated CEOJon Levine. "Revenue growth in the second quarter of 2024 was very strong both year-over-year and sequentially, led by another tremendous quarter for our wholesale business. Our retail business also turned the corner, with a 24% increase in transactions year-over-year...